Maria Abbondanza Pantaleo, Massimo Del Gaudio, Matteo Ravaioli, Matteo Cescon, Margherita Nannini – 8 July 2020
Deepti Abbey, Susannah Elwyn, Nicholas J. Hand, Kiran Musunuru, Daniel J. Rader – 8 July 2020 – Establishment of a physiologically relevant human hepatocyte‐like cell system for in vitro translational research has been hampered by the limited availability of cell models that accurately reflect human biology and the pathophysiology of human disease. Here we report a robust, reproducible, and scalable protocol for the generation of hepatic organoids from human induced pluripotent stem cells (hiPSCs) using short exposure to nonengineered matrices.
Mark Antkowiak, Richard M. Green – 7 July 2020
Mark Antkowiak, Richard M. Green – 7 July 2020
Isabelle Chemin, Flor H. Pujol, Caroline Scholtès, Carmen L. Loureiro, Fouzia Amirache, Massimo Levrero, Fabien Zoulim, Jimena Pérez‐Vargas, François‐Loïc Cosset – 6 July 2020
Marco Spada, Roberta Angelico, Chiara Grimaldi, Paola Francalanci, Maria Cristina Saffioti, Andrea Rigamonti, Rosanna Pariante, Roberto Bianchi, Carlo Dionisi Vici, Manila Candusso, Giuseppe Maggiore – 6 July 2020
Surain B. Roberts, Marwa Ismail, Gowthami Kanagalingam, Andrew L. Mason, Mark G. Swain, Catherine Vincent, Eric M. Yoshida, Cynthia Tsien, Jennifer A. Flemming, Harry L.A. Janssen, Gideon M. Hirschfield, Bettina E. Hansen, Aliya F. Gulamhusein, the Canadian Network for Autoimmune Liver Disease – 6 July 2020 – Patients with primary biliary cholangitis (PBC) with incomplete response to ursodeoxycholic acid are at risk of disease progression and need additional therapy.
Nwe Ni Than, Jose Guillain Cataluna, Avik Majumdar – 6 July 2020
Adam E. Mikolajczyk, Nneka Ufere, Anthony C. Breu, Neehar D. Parikh, Guadalupe Garcia‐Tsao, Elliot B. Tapper – 5 July 2020 – #LiverTwitter has emerged as an academic forum that has begun to advance the field of hepatology by disseminating content on chronic liver diseases to a global audience. This article summarizes the content presented in a panel discussion at the 2019 Liver Meeting by highlighting the perspectives of several key types of participants in Twitter: the trainee, the medical educator, the divisional account, the scientific journal, and the passive participant.